Principal Disease Biologist, Andy Malinowski, will present new PrecisionLife data from our groundbreaking ALS disease studies at the 35th International Symposium on ALS/MND.
We've perfomed new analysis of WGS data from patients diagnosed as having sporadic ALS in Project MinE and Answer ALS using our combinatorial analytics and AI platform which has uncovered novel disease drivers in genetically defined subgroups and the first genetic evidence for targets modulated by existing therapies indicated for ALS/MND and its symptoms.
Combinatorial Analysis of ALS Patients Uncovers New Disease Drivers in Genetically Defined Subgroups
Sesson: Biomedical Progress
Time: 17:30 PM – 19:00 PM (EST)
Date: Saturday, December 7
Send us a request to meet using the form below and connect with us during the event.